Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-06

Clinical Trial Update: Efficacy of Crisaborole 2% Cream Versus Placebo in Mild to Moderate Atopic Eczema [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the efficacy of crisaborole 2% cream versus placebo for mild-to-moderate atopic dermatitis (atopic eczema), with the study liste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Crisaborole 2% Cream (Eucrisa) (crisaborole)

Snippet

Sponsor: Jinnah Postgraduate Medical Centre | Conditions: Atopic Dermatitis (AD), Atopic Eczema | Phase 4 | Status: NOT_YET_RECRUITING